{"id":971645,"date":"2026-06-12T09:30:55","date_gmt":"2026-06-12T13:30:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/"},"modified":"2026-06-12T09:30:55","modified_gmt":"2026-06-12T13:30:55","slug":"mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/","title":{"rendered":"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery<\/b><\/p>\n<p>AUSTIN, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nMindWalk Holdings Corp. (\u201cMindWalk\u201d) (NASDAQ: HYFT), a bio-native AI company, today announced that President and Chief Executive Officer Dr. Jennifer Bath will join a virtual panel hosted by Jones, alongside Absci (NASDAQ: ABSI) and a leading AI compute provider, as part of Jones AI Day. The panel, \u201cPartnering to Power the New Era of Drug Discovery,\u201d will be held on Monday, June 15, 2026, at 12:00 p.m. ET.<\/p>\n<p>\nModerated by Jones Research Senior Research Analysts Dr. Debanjana Chatterjee and Dr. Danya Ben-Hail, the panel will explore how the convergence of high-performance compute, native biological knowledge representations, and generative AI can dismantle longstanding barriers in drug discovery, including prolonged screening timelines and historically undruggable targets.<\/p>\n<p><b>MindWalk\u2019s Perspective<\/b><\/p>\n<p>\nMindWalk is a biology company that built AI on top of 25 years of wet-lab expertise. Its HYFT\u00ae technology powers ReefIQ\u2122, the biological context layer for life sciences, enriching biological data at ingestion and connecting it across a continuously evolving knowledge representation of 660 million biological patterns and 25 billion relationships, with the LensAI\u2122 platform serving as the reasoning and application layer on top. Because predictions are grounded in evolutionary constraint rather than statistical correlation, the architecture is designed to keep both AI models and autonomous agents from hallucinating in the highest-consequence drug discovery workflows. On the panel, Dr. Bath is expected to discuss why the durable asset in biological AI is the enriched context layer rather than any individual model, and how that layer makes agentic AI trustworthy enough to deploy in regulated workflows. LensAI\u2122 is already in contracted, recurring arrangements with life-sciences customers today.<\/p>\n<p>\n\u201cThe hardest problem in drug discovery was never a shortage of compute or models &#8211; it\u2019s that biological data arrives fragmented, and a model reasoning over fragments will confidently get it wrong. Our work grounds that reasoning in what evolution has already constrained, so the biology is connected and real before a model ever acts on it. Paired with compute built for this kind of memory-heavy work, that\u2019s what makes agentic AI trustworthy enough for the highest-consequence workflows. Biology, context, and compute &#8211; that convergence is what I\u2019m looking forward to discussing,\u201d said Dr. Jennifer Bath, PhD, Chief Executive Officer and President of MindWalk Holdings Corp.<\/p>\n<p><b>Panelists<\/b><\/p>\n<p>\nMindWalk (NASDAQ: HYFT): Dr. Jennifer Bath, PhD, Chief Executive Officer and President<br \/>\n<br \/>Absci (NASDAQ: ABSI): Sean McClain, Founder and Chief Executive Officer<br \/>\n<br \/>Leading AI compute provider:<b \/>Senior healthcare and life-science strategy leadership<\/p>\n<p><b>Event Details<\/b><\/p>\n<p>\nEvent: Jones AI Day Virtual Panel, \u201cPartnering to Power the New Era of Drug Discovery\u201d<br \/>\n<br \/>Date and Time:<b \/>Monday, June 15, 2026, 12:00 p.m. ET<\/p>\n<p><b>Format: <\/b>Hosted as part of Jones AI Day (10:30 a.m. to 2:30 p.m. ET), featuring multiple leading AI drug discovery platforms<\/p>\n<p><b>Registration: <\/b>Open to institutional investors through Jones. RSVP to Yuki Gonzalez: <a rel=\"nofollow\" href=\"mailto:ygonzalez@jonestrading.com\">ygonzalez@jonestrading.com<\/a><\/p>\n<p><b>About MindWalk Holdings Corp.<\/b><\/p>\n<p>\nMindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the BioIntelligence infrastructure that life sciences AI and agentic AI require. Its proprietary HYFT\u00ae system powers ReefIQ\u2122, the biological context layer for life sciences \u2014 a function-aware representation organized around HYFT pattern-objects that span sequence and structural biology. Refined over 20 years of curation, this continuously evolving knowledge representation of 660 million biological patterns and 25 billion relationships enriches data at ingestion and compounds in analytical value with every program run on the platform. The LensAI platform operates on this infrastructure to enable target discovery, candidate diligence, and portfolio decision support, and to host the agentic AI workflows pharma is racing to deploy. MindWalk\u2019s architecture is designed so that the HYFT representation layer \u2014 not any individual AI model \u2014 is the durable, compounding competitive asset. References to \u201cMindWalk\u201d in this release refer to MindWalk Holdings Corp. and its subsidiaries, including BioStrand BV, which operates under the MindWalk brand, as the context requires.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nThis press release contains \u201cforward-looking statements\u201d within the meaning of applicable United States securities laws and \u201cforward-looking information\u201d within the meaning of applicable Canadian securities laws (collectively, \u201cforward-looking statements\u201d). Forward-looking statements are often identified by terms such as \u201cexpects,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201ctargets,\u201d \u201cwill,\u201d \u201cis designed to,\u201d or similar expressions, or by statements that certain actions, events, or results are expected, are intended, or will occur or be achieved. Forward-looking statements in this press release include, without limitation, statements regarding: Dr. Bath\u2019s participation in the Jones AI Day virtual panel and the anticipated timing, format, and topics of the event; expectations regarding the convergence of high-performance compute, biological representations, and generative and agentic AI in life sciences; the characterization of the HYFT\u00ae system as powering ReefIQ\u2122, the Company\u2019s biological context layer for life sciences, and of LensAI\u2122 as the reasoning and application layer; the characterization of the biological representation and its scale (660 million biological patterns and 25 billion relationships) and of ReefIQ\u2122 enrichment as enriching data at ingestion and compounding in analytical value over time; the design of the Company\u2019s architecture to keep AI models and autonomous agents from hallucinating and to make agentic AI trustworthy enough to deploy in regulated, high-consequence workflows; and the existence, conversion, and expansion of contracted, recurring arrangements with life-sciences customers.<\/p>\n<p>\nReferences to Jones, Absci, and the other panelists are descriptive of the event and do not imply any endorsement, sponsorship, partnership, commercial agreement, or financial relationship, except as expressly stated. Statements, data, or opinions attributable to other panelists or their respective companies\u2014including any analyst rating, price target, or research opinion\u2014are not those of MindWalk, and MindWalk does not adopt, endorse, or undertake to update them.<\/p>\n<p>\nForward-looking statements are based on management\u2019s current expectations and on assumptions that management believes are reasonable, including assumptions regarding continued customer demand for and adoption of the Company\u2019s platform, the Company\u2019s ability to maintain and scale its technology and infrastructure (including reliance on third-party compute and cloud providers), and the absence of material adverse changes in its business or markets. Such statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially, including, without limitation: that the event may be rescheduled, modified, or cancelled; that adoption of Bio-Native and agentic AI may be slower than anticipated; the Company\u2019s ability to convert engagement into, and to maintain and expand, contracted recurring arrangements; reliance on third-party compute, cloud, and infrastructure providers; competitive dynamics in AI infrastructure and life sciences; intellectual property risks, including patent prosecution and trademark clearance for the ReefIQ\u2122 name; regulatory determinations; and capital markets conditions. There can be no assurance that any candidate, program, or capability referenced will achieve the results described or will be developed, validated, approved, or commercialized.<\/p>\n<p>\nAdditional information regarding risks and uncertainties is available in MindWalk\u2019s Annual Report on Form 20-F and other filings on SEDAR+ (sedarplus.ca) and EDGAR (sec.gov\/edgar). Forward-looking statements speak only as of the date of this press release. Except as required by law, MindWalk undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Nothing in this press release constitutes investment, legal, or tax advice, and this press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful.<\/p>\n<p><b>Trademarks<\/b><\/p>\n<p>\nHYFT\u00ae is a registered trademark of MindWalk Holdings Corp. ReefIQ\u2122 and LensAI\u2122 are trademarks of MindWalk Holdings Corp. or its subsidiaries; ReefIQ\u2122 registration is pending. All other trademarks are the property of their respective owners.<\/p>\n<p><i>Source: MindWalk Holdings Corp<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260612600127\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260612600127\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations Contact<br \/>\n<\/b><br \/>Louie Toma, CPA, CFA<br \/>\n<br \/>Managing Director, CoreIR<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investors@mindwalkai.com\">investors@mindwalkai.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Canada Texas<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Science Biotechnology Research Pharmaceutical Health Artificial Intelligence Infectious Diseases Technology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260612600127\/en\/2586413\/3\/Mindwalk_fullcolor_RGB_LG.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; MindWalk Holdings Corp. (\u201cMindWalk\u201d) (NASDAQ: HYFT), a bio-native AI company, today announced that President and Chief Executive Officer Dr. Jennifer Bath will join a virtual panel hosted by Jones, alongside Absci (NASDAQ: ABSI) and a leading AI compute provider, as part of Jones AI Day. The panel, \u201cPartnering to Power the New Era of Drug Discovery,\u201d will be held on Monday, June 15, 2026, at 12:00 p.m. ET. Moderated by Jones Research Senior Research Analysts Dr. Debanjana Chatterjee and Dr. Danya Ben-Hail, the panel will explore how &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-971645","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; MindWalk Holdings Corp. (\u201cMindWalk\u201d) (NASDAQ: HYFT), a bio-native AI company, today announced that President and Chief Executive Officer Dr. Jennifer Bath will join a virtual panel hosted by Jones, alongside Absci (NASDAQ: ABSI) and a leading AI compute provider, as part of Jones AI Day. The panel, \u201cPartnering to Power the New Era of Drug Discovery,\u201d will be held on Monday, June 15, 2026, at 12:00 p.m. ET. Moderated by Jones Research Senior Research Analysts Dr. Debanjana Chatterjee and Dr. Danya Ben-Hail, the panel will explore how &hellip; Continue reading &quot;MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-12T13:30:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery\",\"datePublished\":\"2026-06-12T13:30:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/\"},\"wordCount\":1368,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/\",\"name\":\"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-06-12T13:30:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/","og_locale":"en_US","og_type":"article","og_title":"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Market Newsdesk","og_description":"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; MindWalk Holdings Corp. (\u201cMindWalk\u201d) (NASDAQ: HYFT), a bio-native AI company, today announced that President and Chief Executive Officer Dr. Jennifer Bath will join a virtual panel hosted by Jones, alongside Absci (NASDAQ: ABSI) and a leading AI compute provider, as part of Jones AI Day. The panel, \u201cPartnering to Power the New Era of Drug Discovery,\u201d will be held on Monday, June 15, 2026, at 12:00 p.m. ET. Moderated by Jones Research Senior Research Analysts Dr. Debanjana Chatterjee and Dr. Danya Ben-Hail, the panel will explore how &hellip; Continue reading \"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-12T13:30:55+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery","datePublished":"2026-06-12T13:30:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/"},"wordCount":1368,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/","name":"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-06-12T13:30:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260612600127r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-nasdaq-hyft-ceo-dr-jennifer-bath-to-join-absci-nasdaq-absi-and-a-leading-ai-compute-provider-on-jones-ai-day-panel-on-the-future-of-ai-drug-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/971645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=971645"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/971645\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=971645"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=971645"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=971645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}